Effect of evolocumab on atherogenic lipoproteins during the peri- And early postinfarction period: A placebo-controlled, randomized trial

Thorsten M. Leucker, Michael J. Blaha, Steven R. Jones, Michael A. Vavuranakis, Marlene S. Williams, Hong Lai, Thomas H. Schindler, Jacqueline Latina, Steven P. Schulman, Gary Gerstenblith

Research output: Contribution to journalLetterpeer-review

12 Scopus citations
Original languageEnglish
Pages (from-to)419-421
Number of pages3
JournalCirculation
Volume142
Issue number4
DOIs
StatePublished - Jul 28 2020

Keywords

  • acute coronary syndrome
  • cholesterol, LDL
  • evolocumab
  • secondary prevention

Cite this